Related Experiment Videos
Management of Flavobacterium meningitis in the neonates: experience with 18 consecutive cases
Abstract:
18 neonates with bacteriologically confirmed Flavobacterium meningitis and ventriculitis were treated with various antibiotic regimens, including the use of intraventricular antibiotics. During the course of treatment, four patients died. 8/14 patients developed progressive hydrocephalus which required insertion of ventriculo-peritoneal shunts. The remainder 6/14 patients had normal ventricles or only mild ventriculomegaly. 5/8 patients with progressive hydrocephalus and 5/6 patients with normal or mildly dilated ventricles were followed up for at least 24 months. 4/5 of the patients with progressive hydrocephalus had severe bilateral hearing loss and delayed milestones. All the 5 patients with normal or mildly dilated ventricles had normal hearing although 2 of them had gross motor delay due to spastic paraplegia. Patients with progressive hydrocephalus received effective antibiotic treatment more than 8 days after the onset of infection while those with normal or mildly dilated ventricles within 8 days of infection. Onset of ventricular dilatation was associated with ventriculitis. Daily ultrasound scanning of the ventricles in the early stage helped to determine the need for early instillation of intraventricular antibiotics. Combined use of intravenous rifampicin, moxalactam and piperacillin showed promise as an effective antibiotic regimen in treating patients with normal or mildly dilated ventricles. Once significant ventriculomegaly has occurred, concomitant intravenous and intraventricular administration of antibiotics, to which the organisms were sensitive, was necessary to eradicate the infection.
Insights
Early antibiotic treatment for neonatal Flavobacterium meningitis and ventriculitis improves outcomes, reducing the risk of hydrocephalus and long-term neurological deficits. Prompt intervention is key for better prognosis in affected neonates.
Area of Science:
- Neonatal Infectious Diseases
- Pediatric Neurology
- Microbiology
Background:
- Neonatal meningitis and ventriculitis caused by Flavobacterium pose significant risks.
- Hydrocephalus and neurological sequelae are common complications.
Purpose of the Study:
- To evaluate the outcomes of antibiotic treatment for neonatal Flavobacterium meningitis and ventriculitis.
- To identify factors influencing prognosis and long-term neurological development.
Main Methods:
- Retrospective analysis of 18 neonates with Flavobacterium meningitis/ventriculitis.
- Assessment of various antibiotic regimens, including intraventricular administration.
- Correlation of treatment timing and hydrocephalus development with neurological outcomes.
Main Results:
- Four of 18 neonates died.
- Progressive hydrocephalus developed in 8/14 patients requiring shunts.
- Patients treated within 8 days had normal or mildly dilated ventricles; those treated later had progressive hydrocephalus.
- Neurological deficits, including hearing loss and motor delay, were more severe in patients with progressive hydrocephalus.
- Combined intravenous and intraventricular antibiotics were necessary for significant ventriculomegaly.
Conclusions:
- Timely antibiotic treatment (within 8 days) is crucial for preventing progressive hydrocephalus and improving neurological outcomes in neonatal Flavobacterium meningitis/ventriculitis.
- Intraventricular antibiotics are essential for managing established ventriculomegaly.
- Specific antibiotic combinations like rifampicin, moxalactam, and piperacillin show promise.